heart failure semaglutide improves symptoms in both sexes—weight loss greater in women Weight loss drug's heart benefits

Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use this medication

Therapeutic Advances in Endocrinology and Metabolism, 6 (1), 1928

What matters is that both trials, in different populations and different durations, produced nearly identical efficacy results

Klara Klein put it: These findings highlight the potential for the first incretin therapy developed specifically for type 1 diabetes to expand treatment options, with the potential to improve glycemic control, support weight management, and ultimately reduce the burden of T1D-related complications. Cardiovascular disease, kidney disease, and other complications are real long-term concerns for people with T1D and weight and glycemic control are directly tied to those risks